Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations
Kaavya Narasimhalu, Yoong Kwei Ang, Doreen Su‐Yin Tan, Deidre Anne De Silva, Kelvin Bryan Tan
Topics & Concepts
ClopidogrelMedicineTicagrelorCYP2C19Internal medicinePopulationStroke (engine)Quality-adjusted life yearCost effectivenessAspirinEngineeringCytochrome P450Environmental healthMechanical engineeringMetabolismRisk analysis (engineering)Antiplatelet Therapy and Cardiovascular DiseasesAcute Ischemic Stroke ManagementBlood Coagulation and Thrombosis Mechanisms